Prevention of pregnancy for women with uterine fibroids or endometriosis
The Women’s Health Clinical Research Center at Penn Medicine is conducting a paid clinical research study to test if an investigational medication is safe and effective in prevention of pregnancy for women with uterine fibroids or endometriosis.
The investigational drug is a tablet that is taken once daily, and all study participants will receive the investigational drug for 12 months. The study will consist of a 12-month treatment period followed by a 12-month follow-up period, which will include 10 in-person visits to the Penn PEACE Clinic at 3737 Market Street, Philadelphia, PA, as well as periodic phone calls and completion of a daily electronic diary. Participants will receive the study medication and study-related tests and exams at no cost, and you may be compensated up to $2,150 total if you complete every part of this study.
You may be eligible for the study if you meet the following criteria:
18-50 years of age
Diagnosed with uterine fibroids or endometriosis
Sexually active with a male partner and seeking contraception/birth control
Not currently pregnant or breastfeeding
Willing to use the study medication as your only form of contraception during the study
Additional study criteria apply
If you are interested in being considered for this study, please fill out the pre-screening survey at this link: https://redcap.link/mct1ocvu
If you have any questions or would like more details about the study, please contact the Family Planning research office at 267-785-8044 and ask about the SERENE study, or email email@example.com.